NCT05281770View on ClinicalTrials.gov

Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions
MigraineMigraine With AuraMigraine Without AuraChronic MigraineEpisodic Migraine
Interventions
DRUG

Erenumab

treatment with erenumab as chosen by treating physician

DRUG

Fremanezumab

treatment with fremanezumab as chosen by treating physician

DRUG

Galcanezumab

treatment with galcanezumab as chosen by treating physician

Trial Locations (3)

1090

RECRUITING

Medizinische Universität Wien, Vienna

A6020

RECRUITING

Medical University Innsbruck, Innsbruck

A1130

RECRUITING

Clinic Hietzing, Vienna

All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

collaborator

Medical University Innsbruck

OTHER

collaborator

Austrian Headache Society

UNKNOWN

lead

Austrian Migraine Registry Collaboration

NETWORK